The Hospital Surgical Disinfectant Market revenues were estimated at US$ 395 Million in 2022 and is anticipated to grow at a CAGR of 7.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 796.6 Million. The demand for hydrogen peroxide is projected to garner an absolute dollar opportunity of US$ 69.5 Million during 2022 – 2032.

According to the Healthcare Cost and Utilization Project (HCUP), approximately 9 Million operations were done in ambulatory care settings in the United States in 2020. In the event of operations, one of the most important needs in healthcare facilities is the use of surgical disinfection solutions. These products are more typically used in hospitals and other medical settings to lower the risk of infection during surgery and other operations because they prevent or limit the development of germs on the skin. As a result, such occurrences are projected to boost the market throughout the forecast period.

Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15796

Surgical and diagnostic procedures may be required, which may require medical consumables Surgical Disinfectant. Hospitalization rates are predicted to rise as the frequency of chronic illnesses such as cardiovascular disease, cancer, diabetes, and other autoimmune disorders rises. The adoption of unhealthy and sedentary lifestyles, as well as antibiotic resistance, are the key factors to the increased prevalence of chronic diseases. According to the National Center for Health Statistics, an estimated 157 million Americans suffer from chronic sickness, with 81 million suffering from several conditions, as of 2018. Because of the rising frequency of chronic diseases, hospital admissions have skyrocketed. Surgical disinfectants are needed in hospitals to keep humans and non-living materials germ-free. Such factors are predicted to drive demand for hospital surgical disinfectants throughout the forecast period.

Competitive Landscape:

Corporations are expanding their corporate footprint in emerging areas through strategic alliances and agreements, as well as focusing on improving distribution networks. This is expected to boost the expansion of the high-level disinfection services market.

The key vendors in the global market are 3M, Ecolab, BD, Sage Products LLC, B. Braun Melsungen AG, Johnson & Johnson, Kimberly-Clark Corporation, Cardinal Health, The Clorox Company, and Schulke & Mayr GmbH, among others.

Some of the recent development in the Hospital Surgical Disinfectant market are:

  • In March 2021, Halsted is reported to have developed the latex glove to protect the hands of his scrub nurse, Caroline Hampton, from the harsh antiseptics in widespread use as disinfectants.
  • In February 2019 Schulke & Mayr struck a distribution deal with DKSH, a key service provider, DKSH will sell and promote a wide variety of Schulke's disinfection products in China under the terms of this agreement.

Key Companies Profiled:

  • 3M
  • Ecolab
  • Becton, Dickinson and Company (BD)
  • Sage Products LLC
  • B. Braun Melsungen AG
  • Johnson & Johnson
  • Kimberly-Clark Corporation
  • Cardinal Health
  • The Clorox Company
  • Schulke & Mayr GmbH

Market Segments Covered in Hospital Surgical Disinfectant Industry Analysis

By Product Type:

  • Chlorhexidine
  • Alcohols
  • Povidone-iodine
  • Octenidine
  • Hydrogen Peroxide
  • Other Product Types

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • Middle East and Africa (MEA)